Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2656-2660

  Robbins, Brian L ^a   Tran, Thu T ^a   Pinkerton Jr , Frank H ^a   Akeb, Fatima ^b   Guedj, Roger ^b   Grassi, Jacques ^c   Lancaster, Danny ^d   Fridland, Arnold ^a,e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CEA SACLAY   (France)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; ZIDOVUDINE; ZIDOVUDINE 5' TRIPHOSPHATE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031691112     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2656     Document Type: Article

References (22)

1. Dienstag, J. L., R. P. Perrillo, E. R. Schiff, M. Bartholomew, C. Vicary, and M. Rubin. 1995. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657-1661.
2. Fletcher, C. V., S. P. Kawle, L. M. Page, R. P. Remmel, E. P. Acosta, K. Henry, A. Erice, and H. H. Balfour. 1997. Intracellular triphosphate concentrations of antiretroviral nucleosides as a determinant of clinical response in HIV-infected patients. In Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C.
3. Furman, P. A., J. A. Fyfe, M. H. Sinclair, K. Weinhold, J. L. Rideout, F. A. Freemen, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
4. Gao, Q., Z. Gu, J. Hiscott, G. Dionne, and M. A. Wainberg. 1993. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37:130-133.
5. Gao, W.-Y., R. Agbaria, J. S. Driscoll, and H. Mitsuya. 1994. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J. Biol. Chem. 269:12633-12638.
6. Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:734-739.
7. Hammer, S. M. 1996. Advances in antiretroviral therapy and viral load monitoring. AIDS 10(Suppl. 3):S1-S3.
8. Hengstschlager, M., C. Denk, and E. Wawra. 1993. Cell cycle regulation of deoxycytidine kinase evidence for post-transcriptional control. FEBS 321:237-240.
9. Larder, B. A., S. D. Kemp, and P. R. Harrigan. 1995. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269:696-699.
10. Merrill, D. P., M. Moonis, T. C. Chou, and M. S. Hirsh. 1996. Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J. Infect. Dis. 173:355-364.
11. Mitchell, B. S., E. E. Johnson, E. Chen, and J. S. Dayton. 1993. Regulation of human deoxycytidine kinase expression Adv. Enzyme Regul. 33:61-68.
12. Munch-Petersen, B., and G. Tyrsted. 1977. Induction of thymidine kinases in phytohaemagglutinin-stimulaled human lymphocytes. Biochim. Biophys. Acta 478:364-375.
13. Perno, C. F., R. Yarchoan, D. A. Cooney, N. R. Hartman, D. A. Webb, Z. Hao, H. Mitsuya, D. G. Johns, and S. Broder. 1989. Replication of human immunodeficiency virus in monocytes granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J. Exp. Med. 169:933-951.
14. Peter, K., J. P. Lalezari, and J. G. Gambertoglio. 1996. Quantification of zidovudine and individual zidovudine phosphates in peripheral blood mononuclear cells by a combined isocratic high performance liquid chromatography radioimmunoassay method. J. Pharm. Biomed. Anal. 14:491-499.
15. Quan, Y., Z. Gu, X. Li, Z. Li, C. D. Morrow, and M. A. Wainberg. 1996. Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2′-dideoxy-3′-thiacytidine by mutated M184V human immunodeficiency virus type 1. J. Virol. 70:5642-5645.
16. Robbins, B. L., B. H. Waibel, and A. Fridland. 1996. Quantitation of intracellular zidovudine phosphates by use of combined cartridge-radioimmunoassay methodology. Antimicrob. Agents Chemother. 40:2651-2654.
17. Rodman, J. H., B. L. Robbins. P. M. Flynn, and A. Fridland. 1996. A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patients. J. Infect. Dis. 174:490-499.
18. Schinazi, R. F., R. M. Lloyd, M. H. Nguyen, D. L. Cannon, A. McMillan, N. Ilksoy, C. K. Chu, D. C. Liotta, H. Z. Bazmi, and J. W. Mellors. 1993. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37:875-881.
19. Schuurman, R., M. Nijhuis, R. Van Leeuwen, P. Schipper, D. De Jong, P. Collis, S. A. Danner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171: 1411-1419.
20. Vaitukaitis, J. L. 1981. Production of antisera with small doses of immunogen: multiple intradermal injections, p. 46-52. In J. J. Langone and H. Van Vunakis (ed.), Methods in enzymology, vol. 73. Academic Press, New York, N.Y.
21. Wong, J. K., M. Hezareh, H. T. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
22. Wring, S. A., R. M. O'Neill, J. L. Williams, W. N. Jenner, M. J. Daniel, M. R. D. Gray, J. J. Newman, C. Wells, and D. R. Sutherland. 1994. The production and evaluation of a radio ligand antiserum for the radioimmunoassay of sub-nanogram per millitre concentration of lamivudine. J. Pharm. Biomed. Anal. 12:1573-1583.